We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-3.47%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$119B
AUM Growth
-$5.47B
Cap. Flow
+$963M
Cap. Flow %
0.81%
Top 10 Hldgs %
23.93%
Holding
4,385
New
262
Increased
2,061
Reduced
1,644
Closed
273

Sector Composition

Rank Sector Weight
1 Technology 14.55%
2 Financials 8.81%
3 Healthcare 8.45%
4 Industrials 6.22%
5 Consumer Discretionary 6.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
A icon
3951
CALL
Agilent Technologies
A
$42.2B
$26K ﹤0.01%
12,900
-500
-4% -$68.8K
STWD icon
3952
CALL
Starwood Property Trust
STWD
$6.17B
$26K ﹤0.01%
20,800
SYBX
3953
DELISTED
Synlogic
SYBX
$26K ﹤0.01%
733
BGFV
3954
CALL
DELISTED
Big 5 Sporting Goods
BGFV
$25K ﹤0.01%
+38,300
New +$682K
TROW icon
3955
CALL
T. Rowe Price
TROW
$24.3B
$25K ﹤0.01%
+12,100
New +$1.87M
GLW icon
3956
CALL
Corning
GLW
$137B
$24K ﹤0.01%
40,000
-15,900
-28% -$620K
ETN icon
3957
CALL
Eaton
ETN
$178B
$23K ﹤0.01%
40,900
-8,300
-17% -$1.3M
PGEN icon
3958
Precigen
PGEN
$2.46B
$23K ﹤0.01%
10,834
-1,375
-11% -$3.35K
WATT icon
3959
Energous
WATT
$103M
$23K ﹤0.01%
32
+1
+3% +$694
WWR icon
3960
Westwater Resources
WWR
$76.3M
$23K ﹤0.01%
11,520
+220
+2% +$446
SIEN
3961
DELISTED
Sientra, Inc.
SIEN
$23K ﹤0.01%
+1,045
New +$28.6K
AMRS
3962
CALL
DELISTED
Amyris Inc.
AMRS
$23K ﹤0.01%
17,600
ADAP
3963
DELISTED
Adaptimmune Therapeutics
ADAP
$22K ﹤0.01%
+10,573
New +$28.5K
RMTI icon
3964
Rockwell Medical
RMTI
$27.9M
$22K ﹤0.01%
427
+100
+31% +$4.24K
ROOT icon
3965
Root
ROOT
$799M
$22K ﹤0.01%
+616
New +$22.2K
BSM icon
3966
CALL
Black Stone Minerals
BSM
$3.02B
$21K ﹤0.01%
+20,000
New +$238K
CLAR icon
3967
CALL
Clarus
CLAR
$146M
$21K ﹤0.01%
29,300
-400
-1% -$9.27K
F icon
3968
CALL
Ford
F
$55.7B
$21K ﹤0.01%
119,000
+43,300
+57% +$823K
FDUS icon
3969
CALL
Fidus Investment
FDUS
$752M
$21K ﹤0.01%
35,100
-200
-0.6% -$3.74K
GYRE icon
3970
Gyre Therapeutics
GYRE
$704M
$21K ﹤0.01%
4,333
-40
-0.9% -$198
KRP icon
3971
CALL
Kimbell Royalty Partners
KRP
$1.5B
$21K ﹤0.01%
93,000
+2,900
+3% +$45.1K
SLV icon
3972
CALL
iShares Silver Trust
SLV
$31.5B
$21K ﹤0.01%
95,900
-59,700
-38% -$1.33M
SNDL icon
3973
Sundial Growers
SNDL
$323M
$21K ﹤0.01%
2,934
+30
+1% +$166
TTOO
3974
DELISTED
T2 Biosystems, Inc
TTOO
$21K ﹤0.01%
8
FRSX
3975
Foresight Autonomous Holdings
FRSX
$4.2M
$20K ﹤0.01%
+143
New +$23.6K

Similar funds

Raymond James & Associates's Q1 2022 Portfolio in Review

As of Q1 2022, Raymond James & Associates held 4,385 positions worth $119B, down 4.4% from $124B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q1 2022 filing shows 262 new, 2,061 increased, 1,644 reduced and 273 closed positions. Its largest new stake was Shell: 688,334 shares worth $37.8M. The largest sale was iShares Ultra Short Duration Bond Active ETF, an estimated $172M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q1 2022 buy was Shell: 688,334 shares worth $37.8M.
  • Raymond James & Associates added most to Broadcom in Q1 2022, an estimated $236M increase.
  • Raymond James & Associates's biggest Q1 2022 reduction was iShares Ultra Short Duration Bond Active ETF, cutting an estimated $172M.
  • Raymond James & Associates fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $154M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $119B portfolio in Q1 2022.
  • Raymond James & Associates opened 262 new positions and closed 273 in Q1 2022.
  • Raymond James & Associates's portfolio value fell 4.4% quarter-over-quarter to $119B.

Based on Raymond James & Associates's 13F filing for Q1 2022, filed 11 May 2022.